Tyrosine kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 491/048 (2006.01) A61K 31/435 (2006.01) A61P 35/00 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2624676

The present invention relates to imidazo[1,2-a]pyrimidine derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

La présente invention concerne des dérivés d'imidazo[1,2-a]pyrimidine, qui sont utiles pour traiter des maladies hyperplasiques, pour traiter des troubles associés à l'activité du récepteur MET, et pour inhiber le récepteur tyrosine kinase MET. L'invention concerne également des compositions comprenant ces composés, ainsi que des méthodes dans lesquelles ces compositions sont utilisées pour traiter le cancer chez les mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1531948

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.